Reuters logo
BRIEF-Pfizer begins Phase 1 clinical trial to evaluate investigational Group B streptococcus vaccine
2017年6月19日 / 中午12点23分 / 3 个月前

BRIEF-Pfizer begins Phase 1 clinical trial to evaluate investigational Group B streptococcus vaccine

June 19 (Reuters) - Pfizer Inc

* Pfizer begins Phase 1 clinical trial to evaluate investigational Group B streptococcus vaccine

* Pfizer Inc - trial will be conducted in United States Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below